Piramal Pharma Limited has informed the Exchange regarding a press release dated April 28, 2026, titled "Piramal Pharma Limited Announces Results for Q4 and Full-year FY26".
Press Release Apr 28 2026
Filed with NSE ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Piramal Pharma
- Piramal Pharma Limited Announces Results for Q4 and Full-year FY26
- Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing
- Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
- Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch
- Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Later from Piramal Pharma
- Piramal Pharma Solutions Unveils State-of-the-Art Payload-Linker Suite at its Riverview, Michigan Facility
- Piramal Pharma Solutions Announces Partnership with Botanix to Support Drug Substance Development
- Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits
- Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
- Piramal Pharma Limited Announces Results for Q1 FY27
Follow Piramal Pharma into a list and get an email when it puts out news.
Follow Piramal Pharma